Saturday 17 October 2026
Export AMWL’s income statement to Excel — free account
American Well Corporation
AMWL Healthcare Health Information Services
American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
11.68
0.70
−5.65%
Follow AMWL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 6 | 6 |
+8 more TTM periods Free account |
| (29.54%) | (32.20%) | (33.93%) | (36.74%) | ||
| (21.82%) | (23.58%) | (25.19%) | (26.93%) | ||
ROIC |
(135.53%) | (95.94%) | (100.51%) | (115.53%) | |
Return on Tangible Assets |
(45.00%) | (50.09%) | (55.10%) | (61.34%) | |
Average Days of Receivables |
87.87 | 87.79 | 72.75 | 76.54 | |
Free Cash Flow per Share |
(1.91) | (2.69) | (4.11) | (3.98) | |
Free Cash Flow |
(32.04) | (44.63) | (65.97) | (64.46) | |
Capital Expenditures |
(5.65) | (2.80) | (0.02) | (2.42) | |
| Other line items | |||||
Cash ROIC |
(7.43%) | (10.62%) | (15.34%) | (13.77%) | |
Accounts Receivable Turnover |
4.12 | 3.68 | 4.10 | 3.66 | |
Accounts Payable Turnover |
38.77 | 28.59 | 34.95 | 17.87 | |
Inventory Turnover |
66.81 | 60.80 | 57.59 | 38.31 | |
Average Days of Payables |
5.89 | 4.53 | 5.17 | 17.26 | |
Days of Inventory on Hand |
3.35 | 3.75 | 3.72 | 5.28 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.02 | |
Research and Development Expense of Revenue |
25.28% | 26.60% | 29.22% | 29.32% | |
Selling, General and Administrative Expense of Revenue |
48.99% | 50.97% | 52.67% | 56.76% | |
Share Based Compensation of Revenue |
5.95% | 7.15% | 8.83% | 10.68% | |
Operating CF/Net income |
0.34 | 0.48 | 0.69 | 0.55 | |
Depreciation/Fixed assets |
217.48 | 209.24 | 167.12 | 149.41 | |
Capex/Depreciation |
(0.16) | (0.08) | 0.00 | (0.07) | |
Revenue per Share |
13.04 | 14.31 | 15.54 | 16.35 | |
Operating CF per Share |
(1.57) | (2.52) | (4.11) | (3.83) | |
Capex per Share |
(0.34) | (0.17) | 0.00 | (0.15) | |
Capex to Sales |
0.03 | 0.01 | 0.00 | 0.01 |
Columns are period end dates